These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19127251)

  • 21. Double suicide gene therapy using human neural stem cells against glioblastoma: double safety measures.
    Lee JY; Lee DH; Kim HA; Choi SA; Lee HJ; Park CK; Phi JH; Wang KC; Kim SU; Kim SK
    J Neurooncol; 2014 Jan; 116(1):49-57. PubMed ID: 24113876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.
    Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS
    Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients.
    Portnow J; Synold TW; Badie B; Tirughana R; Lacey SF; D'Apuzzo M; Metz MZ; Najbauer J; Bedell V; Vo T; Gutova M; Frankel P; Chen M; Aboody KS
    Clin Cancer Res; 2017 Jun; 23(12):2951-2960. PubMed ID: 27979915
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.
    Garcia-Sanchez F; Pizzorno G; Fu SQ; Nanakorn T; Krause DS; Liang J; Adams E; Leffert JJ; Yin LH; Cooperberg MR; Hanania E; Wang WL; Won JH; Peng XY; Cote R; Brown R; Burtness B; Giles R; Crystal R; Deisseroth AB
    Blood; 1998 Jul; 92(2):672-82. PubMed ID: 9657770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined alloreactive CTL cellular therapy with prodrug activator gene therapy in a model of breast cancer metastatic to the brain.
    Hickey MJ; Malone CC; Erickson KL; Lin A; Soto H; Ha ET; Kamijima S; Inagaki A; Takahashi M; Kato Y; Kasahara N; Mueller BM; Kruse CA
    Clin Cancer Res; 2013 Aug; 19(15):4137-48. PubMed ID: 23780889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.
    Aboody KS; Najbauer J; Metz MZ; D'Apuzzo M; Gutova M; Annala AJ; Synold TW; Couture LA; Blanchard S; Moats RA; Garcia E; Aramburo S; Valenzuela VV; Frank RT; Barish ME; Brown CE; Kim SU; Badie B; Portnow J
    Sci Transl Med; 2013 May; 5(184):184ra59. PubMed ID: 23658244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytosine Deaminase-Overexpressing hTERT-Immortalized Human Adipose Stem Cells Enhance the Inhibitory Effects of Fluorocytosine on Tumor Growth in Castration Resistant Prostate Cancer.
    Kim JH; Yang HJ; Lee SH; Song YS
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy.
    Kucerova L; Altanerova V; Matuskova M; Tyciakova S; Altaner C
    Cancer Res; 2007 Jul; 67(13):6304-13. PubMed ID: 17616689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth.
    Kim KY; Kim SU; Leung PC; Jeung EB; Choi KC
    Cancer Sci; 2010 Apr; 101(4):955-62. PubMed ID: 20704576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice.
    Torimura T; Ueno T; Taniguchi E; Masuda H; Iwamoto H; Nakamura T; Inoue K; Hashimoto O; Abe M; Koga H; Barresi V; Nakashima E; Yano H; Sata M
    Cancer Sci; 2012 Mar; 103(3):542-8. PubMed ID: 22151662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor therapeutic effects of cytosine deaminase and interferon-β against endometrial cancer cells using genetically engineered stem cells in vitro.
    Yi BR; Kang NH; Hwang KA; Kim SU; Jeung EB; Choi KC
    Anticancer Res; 2011 Sep; 31(9):2853-61. PubMed ID: 21868529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human neural stem cells expressing carboxyl esterase target and inhibit tumor growth of lung cancer brain metastases.
    Hong SH; Lee HJ; An J; Lim I; Borlongan C; Aboody KS; Kim SU
    Cancer Gene Ther; 2013 Dec; 20(12):678-82. PubMed ID: 24310061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cells with fused gene expression of cytosine deaminase and interferon-β migrate to human gastric cancer cells and result in synergistic growth inhibition for potential therapeutic use.
    Kim KY; Yi BR; Lee HR; Kang NH; Jeung EB; Kim SU; Choi KC
    Int J Oncol; 2012 Apr; 40(4):1097-104. PubMed ID: 22159640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.
    Kim SK; Kim SU; Park IH; Bang JH; Aboody KS; Wang KC; Cho BK; Kim M; Menon LG; Black PM; Carroll RS
    Clin Cancer Res; 2006 Sep; 12(18):5550-6. PubMed ID: 17000692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted Treatment of Experimental Spinal Cord Glioma With Dual Gene-Engineered Human Neural Stem Cells.
    Ropper AE; Zeng X; Haragopal H; Anderson JE; Aljuboori Z; Han I; Abd-El-Barr M; Lee HJ; Sidman RL; Snyder EY; Viapiano MS; Kim SU; Chi JH; Teng YD
    Neurosurgery; 2016 Sep; 79(3):481-91. PubMed ID: 26671631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase/5-fluorocytosine in tumor-bearing mice.
    NguyenThai QA; Sharma N; Luong do H; Sodhi SS; Kim JH; Kim N; Oh SJ; Jeong DK
    J Gene Med; 2015; 17(3-5):87-99. PubMed ID: 25808408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine.
    Van Rite BD; Harrison RG
    Cancer Lett; 2011 Aug; 307(1):53-61. PubMed ID: 21546157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
    Kazlauskas A; Darinskas A; Meškys R; Tamašauskas A; Urbonavičius J
    BMC Cancer; 2019 Mar; 19(1):197. PubMed ID: 30832616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
    Zhang J; Wei F; Wang H; Li H; Qiu W; Ren P; Chen X; Huang Q
    Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytosine deaminase-expressing human neural stem cells inhibit tumor growth in prostate cancer-bearing mice.
    Lee HJ; Doo SW; Kim DH; Cha YJ; Kim JH; Song YS; Kim SU
    Cancer Lett; 2013 Jul; 335(1):58-65. PubMed ID: 23391716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.